Brief report: relationship between serum infliximab concentrations and risk of infections in patients treated for spondyloarthritis

T Bejan‐Angoulvant, D Ternant, F Daoued… - Arthritis & …, 2017 - Wiley Online Library
Objective Tumor necrosis factor inhibitors are effective in reducing inflammation in rheumatic
diseases but increase the risk of infections. This study was undertaken to investigate the …

Orbital myositis and primary Sjögren syndrome

FX Danlos, F Daoued, R Seror, X Mariette - The Journal of …, 2015 - jrheum.org
In this report, we describe a new systemic manifestation associated with primary Sjögren
syndrome (pSS): orbital myositis (OM). Considered a systemic disorder, pSS is primarily …

IgG4-related disease associated with renal microaneurysms and polycythaemia

FX Danlos, F Daoued-Keffi, J Rohmer, G Cluzel… - …, 2016 - academic.oup.com
SIR, In this report, we describe the first case of IgG4-related disease (IgG4-RD) revealed by
renal involvement mimicking polyarteritis nodosa with secondary polycythaemia. A 60-year-…

AB0417 Frequency, Time Course and Outcomes of Infliximab-Induced Liver Injury in Rheumatic Diseases

F Medina, D Mulleman, N El Gani, Y Bacq… - 2015 - ard.bmj.com
… Acknowledgements: The authors thank Fadela Daoued and Alexis Lhommas for their
cooperation for the collection of data. We are indebted to all the clinicians, Isabelle Griffoul, …

AB0416 Early Good Eular Response Predicts Low/Remission Disease State in Rheumatoid Arthritis Patients on Treatment with Certolizumab in Real Life Settings …

F Iannone, G Carlino, A Marchesoni, P Sarzi-Puttini… - 2015 - ard.bmj.com
… Acknowledgements: The authors thank Fadela Daoued and Alexis Lhommas for their
cooperation for the collection of data. We are indebted to all the clinicians, Isabelle Griffoul, …

AB0419 Determination of Anti-Drug Antibodies in Long-Term Treatment of Rheumatoid Arthritis Patients with Etanercept

S Drynda, R Beuermann, J Kekow - 2015 - ard.bmj.com
… Acknowledgements: The authors thank Fadela Daoued and Alexis Lhommas for their
cooperation for the collection of data. We are indebted to all the clinicians, Isabelle Griffoul, …

AB0418 Effectiveness of Rituximab as First and Second Line Therapy in Patients with Rheumatoid Arthritis

I Mahmoud, S Jradi, O Saidane, S Rekik, H Sahli… - 2015 - ard.bmj.com
… Acknowledgements: The authors thank Fadela Daoued and Alexis Lhommas for their
cooperation for the collection of data. We are indebted to all the clinicians, Isabelle Griffoul, …

[CITATION][C] Fréquence des événements indésirables chez les patients traités par infliximab en rhumatologie

F Daoued - 2013

Suivi thérapeutique pharmacologique des anti-TNF-α au cours des spondyloarthrites

D Mulleman, P Goupille, G Paintaud - Revue du Rhumatisme …, 2015 - Elsevier
Les biomédicaments anti-TNF-α ont profondément changé notre façon de traiter les formes
sévères et réfractaires de spondyloarthrites (SpA). Cependant, la réponse clinique est …

Management and outcome of native joint septic arthritis: A nationwide survey in French rheumatology departments, 2016–2017

P Richebé, G Coiffier, P Guggenbuhl… - Annals of the …, 2022 - ard.bmj.com
Objectives To describe current management and outcome of native joint septic arthritis (NJSA)
in French rheumatology departments. Methods For this retrospective, nationwide …